XPost: alt.health, alt.politics, alt.fan.rush-limbaugh

https://www.telegraph.co.uk/news/2025/05/26/first-new-antibiotic-in-50-years-to-tackle-superbug/

Zosurabalpin works differently to all existing drugs and may
lay foundation for development of new treatments

The first new antibiotic in 50 years to tackle a common superbug
will be tested on patients.

The drug, which targets one of the bacteria considered to pose
the biggest threat to human health, has been hailed as an
“exciting” development in the fight against antibiotic
resistance.

On Monday, Roche, the Swiss pharmaceutical giant, announced
that it will take zosurabalpin into the third and last phase
of testing on humans.

It is the first drug in five decades to show promise of
tackling Acinetobacter baumannii, a pathogen which is
described as a “priority” by the World Health Organisation
and an “urgent threat” by the Centers for Disease Control
and Prevention, the US national public health agency.

The drug-resistant bacteria disproportionately impact
patients who are in the hospital, causing infections
such as pneumonia and sepsis.

It is estimated that between 40 and 60 per cent of infected
patients, many of whom are immunocompromised because of
conditions such as cancer, die as a result of the bug.

. . .

The SCARY bit is that this is the first really
new class of antibiotics in FIFTY YEARS.

This line of attack on bacteria is clearly ending.
Collectively they're too smart.

The future is likely next-gen mRNA and viral
defenses. Get right into their little brains
and SCRAMBLE them.

But real-world meds - things you can GET -
likely years off still.

--- SoupGate-Win32 v1.05
* Origin: fsxNet Usenet Gateway (21:1/5)